Publications
Publications
Show Results For
- All HBS Web
(4,350)
- Faculty Publications (674)
- January 2010 (Revised October 2010)
- Case
Colombia: Strong Fundamentals, Global Risk
By: Aldo Musacchio, Richard H. K. Vietor, Jonathan Schlefer and Carolina Camacho
By mid-2009 Colombian President Alvaro Uribe had ended decades of virtual civil war and strengthened the business climate, but he faced tough economic challenges. Though he had instituted prominent market reforms and brought inflation down sharply, Colombia seemed... View Details
- 2010
- Working Paper
International Capital Allocation, Sovereign Borrowing, and Growth
By: Laura Alfaro, Sebnem Kalemli-Ozcan and Vadym Volosovych
The key in the investigation of "where" and "why" capital flows, relative to the neoclassical benchmark, is how we measure these flows. The macro literature has been using three main yardsticks: the current account balance, returns to capital, and the volume of net... View Details
- December 2009
- Article
From a Declaration of Values to the Creation of Value in Global Health
By: Jim Yong Kim, Joseph Rhatigan, Sachin H. Jain and Michael E. Porter
To make best use of the new dollars available for the treatment of disease in resource poor settings, global health practice requires a strategic approach that emphasizes value for patients, defined as health outcomes per dollar spent. Practitioners and global health... View Details
- December 2009
- Article
Media Markets and Localism: Does Local News en Español Boost Hispanic Voter Turnout?
By: Felix Oberholzer-Gee and Joel Waldfogel
Since the dawn of broadcasting, and especially in the past decade, Americans have turned their attention from local to more distant sources of news and entertainment. While the integration of media markets will raise the private welfare of many consumers, critics of a... View Details
- November 2009 (Revised August 2010)
- Case
NovoCure Ltd.
By: William A. Sahlman and Sarah Flaherty
Venture capitalist William Doyle must raise $35 million for a portfolio company with a promising, novel cancer therapy, just as global capital markets are imploding in the fall of 2008. NovoCure, Ltd., has developed an electrical-field-based therapy, called Tumor... View Details
- November 2009 (Revised January 2011)
- Case
International AIDS Vaccine Initiative
By: Allen S. Grossman and Cathy Ross
Dedicated to accelerating the development of a safe, effective, accessible, preventive HIV vaccine, the International AIDS Vaccine Initiative (IAVI) pioneered ways of addressing the inadequate incentive structures that prevented progress toward vaccines for AIDS and... View Details
- October 2009
- Teaching Note
Global Health Partner: Obesity Care
By: Michael E. Porter, Zayed Muhammed Yasin and Jennifer F Baron
Teaching Note for [709494]. View Details
- October 2009 (Revised July 2013)
- Case
Gilead Sciences, Inc.: Access Program
By: V. Kasturi Rangan and Katharine Lee
Gilead Sciences, the U.S. leader in HIV/AIDS medicines, with global sales of $5.4 billion in 2009, had undertaken several innovative actions to make its anti-viral products available to over 100 low- and middle-income countries. Having reached nearly 680,000 patients... View Details
- September 2009 (Revised May 2011)
- Case
Acumen Fund: Measurement in Impact Investing (A)
By: Alnoor Ebrahim and V. Kasturi Rangan
Acumen Fund is a global venture capital firm with a dual purpose: it looks for a return on its investments, and it also seeks entrepreneurial solutions to global poverty. This case examines Acumen's new projects in Kenya. The organization's investment committee and its... View Details
- August 2009 (Revised April 2012)
- Case
Genzyme's CSR Dilemma: How to Play its HAND
By: Christopher A. Bartlett, Tarun Khanna and Prithwiraj Choudhury
Genzyme, a global biotechnology company, launches a program to develop therapies for neglected diseases (e.g., malaria, TB), giving away the intellectual property. This case focuses on the decision of which diseases, which partnerships, and which markets should... View Details
- May 2009
- Case
Global Health Partner: Obesity Care
By: Michael E. Porter, Zayed Muhammed Yasin and Jennifer F Baron
Global Health Partner (GHP) was founded in 2006 as a privately owned health care provider in Sweden serving both public and private paying patients. In contrast to most providers in the country, GHP organized around specific service lines where it saw the potential to... View Details
- 22 Apr 2009
- Other Presentation
Redefining Global Health Care: Narrowing the Gap Between Aspiration and Action
By: Michael E. Porter and Jim Yong Kim
Gaps in health financing, human resources, and access to care have fatal consequences for millions in developing countries. View Details
- April 2009 (Revised May 2010)
- Case
Partners In Health: HIV Care in Rwanda
By: Michael E. Porter, Scott S. Lee, Joseph Rhatigan and Jim Yong Kim
In 2005, Partners in Health (PIH) was invited by the Rwandan Ministry of Health to assume responsibility for the management of public health care in two rural districts in Eastern Rwanda and create an HIV treatment program at these sites. PIH successfully implemented a... View Details
- 2 Apr 2009
- Other Presentation
Redefining Health Care Delivery: Implications for Global Health
This presentation draws on Michael E. Porter and Elizabeth Olmsted Teisberg: Redefining Health Care: Creating Value-Based Competition on Results, Harvard Business School Press, May 2006, and ―How Physicians Can Change the Future of Health Care, Journal of the American... View Details
- March 2009
- Teaching Note
Sex, Drugs, and Rock 'n Roll: The MTV Approach to Tackling HIV/AIDS (TN)
By: Tarun Khanna, Sonali R. Bloom and David E. Bloom
Teaching Note for [709429]. View Details
- February 2009 (Revised December 2009)
- Case
Merck: Global Health and Access to Medicines
By: V. Kasturi Rangan and Katharine Lee
The case describes the effort of Merck, a global leader in pharmaceuticals, in making available its medicines to the poor. The challenge for the company (or for that matter, any pharmaceutical company) is how to integrate its business strategy with its corporate social... View Details
- February 2009 (Revised April 2011)
- Case
Yahoo! in China (A)
By: Sandra J. Sucher and Daniel Baer
In 2007 Jerry Yang, CEO of Yahoo!, was lambasted by U.S. Representative Tom Lantos, chairman of the U.S. House Committee on Foreign Affairs, for Yahoo's role in the arrest and imprisonment of Chinese journalist and democracy advocate Shi Tao. The case describes the... View Details
- Article
A Blueprint for Pharmacy Benefits Managers to Increase Value
By: William Shrank, Michael E. Porter, Sachin H. Jain and Niteesh K. Choudhary
Pharmacy benefits managers (PBMs) have a unique opportunity to promote public health and generate value in the healthcare system. However, PBMs are largely evaluated on their ability to control costs rather than improve health. PBMs should be evaluated along three... View Details
- December 2008 (Revised March 2009)
- Case
The World Food Programme during the Global Food Crisis (A)
By: Anette Mikes, Peter Tufano, Eric D. Werker and Jan-Emmanuel De Neve
Rising food prices threatened an unprecedented number of people around the world with malnutrition or starvation in 2008. The new Executive Director of the United Nations' World Food Programme (WFP)—the world's largest food relief agency—must not only address this... View Details
- 2008
- Book
On Competition
By: M. E. Porter
Competition is one of society's most powerful forces for making things better in many fields of human endeavor. The study of competition and the creation of value, in their full richness, have preoccupied me for several decades. Competition is pervasive, whether it... View Details